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Background: Short interfering RNAs (siRNAs) are often used to deplete viral polycistronic transcripts, such as those
encoded by human papillomavirus (HPV). There are conflicting data in the literature concerning how siRNAs
targeting one HPV gene can affect levels of other genes in the polycistronic transcripts. We hypothesised that the
conflict might be partly explained by the method of cDNA synthesis used prior to transcript quantification.
Findings: We treated HPV16-positive cervical keratinocytes with siRNAs targeting the HPV16 E7 gene and used
quantitative PCR to compare transcript levels of E7 with those of E6 and E2, viral genes located upstream and
downstream of the target site respectively. We compared our findings from cDNA generated using oligo-dT
primers alone with those from cDNA generated using a combination of random hexamer and oligo-dT primers. Our
data show that when polycistronic transcripts are targeted by siRNAs, there is a period when untranslatable cleaved
mRNA upstream of the siRNA binding site remains detectable by PCR, if cDNA is generated using random hexamer
primers. Such false indications of mRNA abundance are avoided using oligo-dT primers. The period corresponds to
the time taken for siRNA activity and degradation of the cleaved transcripts. Genes downstream of the siRNA
binding site are detectable during this interval, regardless of how the cDNA is generated.
Conclusions: These data emphasise the importance of the cDNA synthesis method used when measuring
transcript abundance following siRNA depletion of polycistronic transcripts. They provide a partial explanation for
erroneous reports suggesting that siRNAs targeting HPV E7 can have gene-specific effects.
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Gene depletion using siRNAs is an important tool in
biological investigations and clinical therapeutics. It is
often applied for depleting polycistronic transcripts,
particularly those derived from viruses [1]. One example is
high-risk human papillomavirus (HR-HPV), the necessary
cause of cervical carcinoma [2]. Numerous siRNAs have
been designed to target the major HR-HPV oncogenes E6
and E7. These genes are expressed in multiple polycis-
tronic transcripts, in which E6 is upstream of E7 [3]. In
cells where HR-HPV is integrated into host DNA the* Correspondence: nc109@cam.ac.uk
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reproduction in any medium, provided the ortranscripts often contain E6 and E7 only, whereas in cells
where the virus remains extra-chromosomal (episomal)
there are additional downstream genes, including E2.
There are conflicting reports regarding the effect of
particular siRNAs on expression of other genes in the
polycistronic transcripts, as assessed using quantitative
reverse-transcription PCR (qRT-PCR). While some
studies show that siRNAs targeting E7 also deplete E6
(and vice versa) [4,5], there is also widely-cited evidence
that siRNAs can specifically deplete E7 without affecting
E6 [6].
We hypothesised that the different results reported
may be partly explained by the method used to generatel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Sequences of siRNAs targeting HPV16 E7
siRNA source Name siRNA sense (passenger) strand
sequence
Tang [4] Tang GCACACACGUAGACAUUCG
Dharmacon 127 GGACAAGCAGAACCGGACA
Dharmacon 141 GGACAGAGCCCAUUACAAU
Dharmacon 653 GCUCAGAGGAGGAGGAUGA
Yamato [5] Y573 CACCUACAUUGCAUGAAUA
Jiang and Milner [6] Jiang AGGAGGAUGAAAUAGAUGG
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oncogenes. Binding of siRNAs can result in cleaved tran-
scripts that are subsequently degraded, at a rate that varies
between systems [7]. While mRNA upstream of the cleav-
age site would not be translated, as it has no polyA tail,
the genes encoded would still be detectable by PCR if
cDNA was generated using random hexamer primers. In
contrast, mRNA upstream of the cleavage site would not
be detectable if cDNA was generated using oligo-dT
primers, which would only generate cDNA from down-
stream of the cleavage site.
We initially tested this hypothesis by treating the
HPV16-positive cervical squamous cell carcinoma (SCC)
cell line CaSki [8] with siRNAs targeting HPV16 E7 and
measuring levels of E7 and the upstream gene E6. We
used six different siRNAs that mapped along the E7
open reading frame (Table 1 and Figure 1) [9]. Cells
were transfected according to manufacturer’s instructions
using Lipofectamine RNAiMAX (Invitrogen, Paisley, UK)
and 9nM siRNA. To control for non-specific siRNA
effects, a pool of non-targeting control siRNAs (ON-TAR-
GET plus non-targeting, Thermo Scientific) was used, also
at 9nM. RNA was extracted using TRIzol (Life Technolo-
gies, Grand Island, NY, USA) according to manufacturer’s
instructions. Twenty-four hours after each treatment,
cDNA was generated using two different methods: a com-
bination of random hexamer and oligo-dT primers
(QuantiTect reverse transcription kit, Qiagen, Crawley,
UK), and oligo-dT primers alone (Qiagen, UK). Levels ofE6 E7 
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Figure 1 Location of siRNA and PCR primer binding sites. A representa
siRNAs and PCR primers used in the present study. Full details of the rangeHPV16 E7 and E6 were then measured by qRT-PCR as
described [9], using the primers listed in Table 2. Primer
binding sites are illustrated in Figure 1.
Across the siRNAs, the mean level of E7 depletion
measured at 24 hours was 74.7% (range 59.2-84.2%) for
cDNA made with random hexamer and oligo-dT
primers and 71.6% (46.1-84.8%) for cDNA made with
oligo-dT primers alone (Figure 2A). For cDNA made
using oligo-dT primers only, levels of E6 mirrored those
of E7 (Figure 2B). In contrast, for all six siRNAs, when
using cDNA made with combined random hexamer and
oligo-dT primers, E6 reductions were significantly lower
than E7 (Figure 2B), with a mean reduction of 41.9%
(range 31.8-50.8%) (P-value = 0.00011, t-test). Such
differences between E6 and E7 levels were greatest for
the siRNAs that produced the greatest depletion of E7,
although the trend was maintained for all siRNAs.
The most potent siRNA, E7-141, was subsequently
optimised for transfection in a different HPV16-
containing cervical squamous cell line, W12 series-4
passage-86 (W12Ser4p86) [10]. These cells reform an SCC
in organotypic tissue culture and stably retain approxi-
mately 500 episomes of HPV16 per cell. They therefore
express polycistronic transcripts in which E6 is upstream
of E7, with other early genes including E2 downstream
[10]. We predicted that levels of E6 depletion determined
following cDNA synthesis using oligo-dT primers would
be greater than those determined following cDNA synthe-
sis using random hexamer primers but that depletion of
E2 would be similar for both cDNA synthesis methods.
Furthermore, measuring the disparities in viral gene
levels over time would allow us to detect the interval
over which siRNA activity and degradation of cleaved
transcripts occurred. Accordingly, we measured of E7,
E6 and E2 at 24, 48 and 96 hours following E7-141
treatment of W12Ser4p86.
As with CaSki, E7-141 treatment produced mean E7
depletion levels of 82.4%, which did not vary significantly
over the time-period studied and did not differ
according to cDNA synthesis method (Figure 2C). At
24 hours following treatment the levels of E6 depletionE2 E5 
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tive HPV16 polycistronic transcript, showing the binding sites of the
of HPV16 polycistronic transcripts are provided elsewhere [3].
Table 2 Primers used for qRT-PCR
Target Forward primer (5’ to 3’) Reverse primer (5’ to 3’)
HPV16 E7 AGGAGGATGAAATAGATGGTCC CTTTGTACGCACAACCGAAGC
(nt 662–773)
HPV16 E6 AGCGACCCAGAAAGTTACCA GCATAAATCCCGAAAAGCAA
(nt 105–219)
HPV16 E2 GGAGACTCTTTGCCAACGTTTA CACATTCTAGGCGCATGTGT
(nt 2931–3080)
GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG
TBP Hs_TBP_1_SG (Qiagen)
ACTB Hs_ACTB_2_SG (Qiagen)
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similar to those determined for E7 (70.0% for E6, 76.6%
for E7: Figure 2C and D), whereas the levels of E6 deple-
tion determined in cDNA generated by random hexamers
and oligo-dT were significantly less (23.6%, P-value =
0.01359, t-test) (Figure 2D). Levels of E2 depletion at
24 hours were very low (mean = 4.9%), regardless of the
cDNA synthesis method (Figure 2E). In contrast, at 48
and 96 hours, levels of E6 and E2 depletion determined by
PCR were similar to those of E7, regardless of the cDNA
synthesis method (Figure 2C-E).
Our data are consistent with the model shown in
Figure 3. Treatment with E7-targetting siRNAs leads
to cleavage of the HPV16 polycistronic transcripts
around the site of binding, preventing detection of the
target gene E7 regardless of the mode of cDNA synthesis.A
C D
Figure 2 RT-PCR quantification of HPV16 mRNA depletion in E7-siRNA
after treatment of CaSki with E7-targeting siRNAs. The bottom row shows l
of W12Ser4p86 with E7-141 siRNAs. Each pair of bars shows levels detected
(red) or oligo-dT and random hexamer primers (green). Error bars show the
NTC = non-targeting control.However, as siRNA activity and degradation of the cleaved
transcripts progress, there is a window (between 24 and
48 hours in our W12 experiment) where misleading infor-
mation may be obtained. For genes in the transcript that
are upstream of the siRNA binding site (E6 in our experi-
ments), PCR quantification using cDNA generated by ran-
dom hexamers will detect untranslatable transcripts and
so give an inappropriately high indication of gene abun-
dance. A more appropriate measure of the abundance of
such upstream genes would be provided by cDNA gener-
ated using oligo-dT primers alone. For genes in the poly-
cistronic transcript that are downstream of the siRNA
binding site (such as E2), cDNA generated using either
random hexamers or oligo-dT primers would give a falsely
high indication of gene abundance, until siRNA activity
and degradation of the cleaved transcript is complete.B
E
treated cells. The top row shows levels of A) E7 and B) E6 24 hours
evels of C) E7, D) E6 and E) E2 at 24, 48 and 96 hours after treatment
in the same cells using cDNA generated by oligo-dT primers only
standard deviations, based on three independent experiments.
Figure 3 Model for the effects of cDNA synthesis method on PCR quantification of polycistronic transcript genes following siRNA
treatment. The Figure shows the representative early HPV16 polycistronic transcript from Figure 1. Following treatment with E7-targeting siRNA,
the transcript is cleaved around the siRNA binding site (second row). If PCR transcripts are quantified using cDNA generated with random
hexamer and oligo-dT primers (left side), genes upstream of the cleavage site (in this schematic, E6) will be detected even though they are not
translatable, until siRNA activity and degradation of the cleaved fragments is complete. In contrast, using cDNA generated with oligo-dT primers
alone (right side) will not lead to false detection of such upstream genes. Both methods of cDNA synthesis will lead to misleading PCR detection
of genes downstream of the cleavage site (in this schematic, E2), until completion of siRNA activity and fragment degradation. For both cDNA
synthesis methods the cleaved target gene (in this schematic, E7) will not be detected by PCR.
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conflicting observations in the literature concerning the
specificity of siRNAs targeting HPV16 E7. The previous
study that showed evidence of E7-specific effects [6] is
likely to have quantified E6 in cleaved but undegraded
mRNAs, as random decamers were included in the
Reverse-iT reverse transcription kit used. It should be
noted that differences in E6 versus E7 levels in the previ-
ous study persisted to 48 hours in CaSki and SiHa cells,
in contrast to our present findings in W12. There was
also continued suppression of p53 protein until 72 hours
in cells treated with E7 siRNAs, although the presump-
tion that this represented the sustained presence of E6
protein was not tested directly [6]. These caveats aside,
our data suggest that when siRNAs are used to target
any polycistronic mRNA transcript (i.e. not just those
derived from HPV), careful consideration should begiven to the method of cDNA synthesis and the relative
binding sites of the PCR primers and siRNAs used.
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